A prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy

J Am Coll Cardiol. 2005 Mar 1;45(5):722-9. doi: 10.1016/j.jacc.2004.08.069.

Abstract

Objectives: We sought to derive and validate a score to estimate risk after adenosine stress.

Background: Maximizing the prognostic information extracted from adenosine stress myocardial perfusion scintigraphy, a commonly performed test, is often challenging for referring physicians.

Methods: A split-set validation of a score predicting cardiovascular mortality was performed in 5,873 consecutive patients studied by adenosine stress, dual-isotope single-photon emission computed tomography (SPECT; follow-up 94% complete, mean 2.2 +/- 1.1 years).

Results: On follow-up, 387 cardiac deaths occurred (6.6%). The Cox proportional hazards model most predictive of cardiac death included age, % myocardium ischemic, % myocardium fixed, early revascularization, dyspnea, diabetes mellitus, rest and peak stress heart rates, abnormal rest electrocardiogram (ECG), and an interaction between % myocardium ischemic and early revascularization (chi-square = 376). The final prognostic score was calculated as follows: (age [decades] x 5.19) + (% myocardium ischemic [per 10%] x 4.66) + (% myocardium fixed [per 10%] x 4.81) + (diabetes mellitus x 3.88) + (if patient treated with early revascularization, 4.51) + (if dyspnea was a presenting symptom, 5.47) + (resting heart rate [per 10 beats] x 2.88) - (peak heart rate [per 10 beats] x 1.42) + (ECG score x 1.95) - (if patient treated with early revascularization, % myocardium ischemic [per 10%] x 4.47). Scores of <49, 49 to 57, and >57 identified low, intermediate, and high risk (0.9%, 3.3%, and 9.5% cardiac death/year, respectively). Score results further risk stratified patients with respect to cardiac death in all categories of SPECT abnormality.

Conclusions: We derived and validated a score incorporating data available after adenosine stress perfusion SPECT. This score maximizes the prognostic information extracted from this test and may enhance the application of this test as part of an overall strategy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine*
  • Aged
  • Aged, 80 and over
  • Cause of Death
  • Coronary Circulation / physiology*
  • Coronary Disease / diagnostic imaging*
  • Coronary Disease / mortality
  • Electrocardiography / drug effects
  • Exercise Test*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Myocardial Infarction / mortality*
  • Predictive Value of Tests
  • Prognosis
  • Risk Assessment
  • Tomography, Emission-Computed, Single-Photon*

Substances

  • Adenosine